Susan M. Kanaya is CFO & VP +1 at ChemoCentryx, Inc. (CCXI). They have made 26 open-market trades across 1 company since 2012, most recently 2022-10-20.
CIK 0001226064
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CCXI | 91,317 | $972K |
Shares reported on the most recent Form 4, priced at the 2022-08-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCXI | SELL | 2022-08-16 | 2022-08-18 | $50.95 | $2.0M | +0.2% | +1.3% | -79.8% |
| CCXI | SELL | 2022-08-04 | 2022-08-08 | $50.17 | $4.6M | +0.6% | +1.6% | -79.8% |
| CCXI | SELL | 2020-06-12 | 2020-06-16 | $64.58 | $3.2M | -14.0% | -10.3% | -16.0% |
| CCXI | SELL | 2020-05-04 | 2020-05-06 | $54.61 | $8.2M | +5.8% | +8.5% | -1.8% |
| CCXI | SELL | 2020-02-19 | 2020-02-21 | $50.14 | $1.2M | +7.9% | -20.2% | +27.0% |
| CCXI | SELL | 2020-02-11 | 2020-02-13 | $49.60 | $2.5M | -6.4% | -30.0% | +5.1% |
| CCXI | SELL | 2020-02-03 | 2020-02-05 | $45.09 | $9.3M | +2.1% | -1.0% | +13.9% |
| CCXI | SELL | 2020-01-16 | 2020-01-17 | $41.00 | $5.2M | -5.8% | +12.4% | +7.8% |
| CCXI | SELL | 2019-11-26 | 2019-11-27 | $30.99 | $12.5M | +7.8% | +25.4% | +60.5% |
| CCXI | SELL | 2019-11-26 | 2019-11-27 | $31.49 | $9.8M | +7.8% | +25.4% | +60.5% |
| CCXI | SELL | 2019-03-27 | 2019-03-29 | $13.05 | $457K | -1.9% | -2.1% | -35.7% |
| CCXI | SELL | 2019-01-22 | 2019-01-24 | $12.08 | $915K | -2.0% | -9.1% | +5.9% |
| CCXI | SELL · 10b5-1 | 2018-06-29 | 2018-07-03 | $14.10 | $1K | -0.7% | -12.4% | -4.2% |
| CCXI | SELL | 2018-06-28 | 2018-06-28 | $14.00 | $98K | -6.1% | -21.5% | -6.9% |
| CCXI | SELL | 2018-06-27 | 2018-06-28 | $13.25 | $651K | -6.1% | -21.5% | -6.9% |
| CCXI | SELL | 2018-06-26 | 2018-06-28 | $13.52 | $1.3M | -6.1% | -21.5% | -6.9% |
| CCXI | SELL | 2018-05-15 | 2018-05-17 | $11.14 | $185K | +1.8% | -0.9% | -9.2% |
| CCXI | SELL | 2018-05-08 | 2018-05-10 | $11.53 | $1.5M | +17.7% | +9.6% | +5.9% |
| CCXI | SELL · 10b5-1 | 2018-05-02 | 2018-05-04 | $11.50 | $16K | +11.5% | +7.6% | +0.0% |
| CCXI | SELL | 2016-01-22 | 2016-01-22 | $4.06 | $61K | -10.1% | -12.1% | -35.5% |
| CCXI | SELL | 2016-01-21 | 2016-01-22 | $4.04 | $208K | -10.1% | -12.1% | -35.5% |
| CCXI | SELL | 2016-01-20 | 2016-01-20 | $4.10 | $61K | -7.9% | -8.8% | -43.2% |
| CCXI | SELL | 2016-01-15 | 2016-01-20 | $4.08 | $174K | -7.9% | -8.8% | -43.2% |
| CCXI | SELL | 2016-01-08 | 2016-01-12 | $5.12 | $52K | -11.3% | -23.8% | -44.2% |
| CCXI | SELL | 2016-01-08 | 2016-01-12 | $5.12 | $52K | -11.3% | -23.8% | -44.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.